title: Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.
abstract: Toxoplasma gondii is an obligate intracellular parasite that permanently infects warm-blooded vertebrates through its ability to convert into a latent tissue cyst form. The latent form (bradyzoite) can reinitiate a life-threatening acute infection if host immunity wanes, most commonly in AIDS or organ transplant patients. We have previously shown that bradyzoite development is accompanied by phosphorylation of the parasite eukaryotic initiation factor 2 alpha subunit (eIF2α), which dampens global protein synthesis and reprograms gene expression. In this study, we analyzed the activities of two specific inhibitors of eIF2α dephosphorylation, salubrinal (SAL) and guanabenz (GA). We establish that these drugs are able to inhibit the dephosphorylation of Toxoplasma eIF2α. Our results show that SAL and GA reduce tachyzoite replication in vitro and in vivo. Furthermore, both drugs induce bradyzoite formation and inhibit the reactivation of latent bradyzoites in vitro. To address whether the antiparasitic activities of SAL and GA involve host eIF2α phosphorylation, we infected mutant mouse embryonic fibroblast (MEF) cells incapable of phosphorylating eIF2α, which had no impact on the efficacies of SAL and GA against Toxoplasma infection. Our findings suggest that SAL and GA may serve as potential new drugs for the treatment of acute and chronic toxoplasmosis.
authors: Department of Biochemistry & Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
authors: Christian
authors: C
authors: Konrad
authors: Sherry F
authors: SF
authors: Queener
authors: Ronald C
authors: RC
authors: Wek
authors: William J
authors: WJ
authors: Sullivan
mesh_terms: D000818:Animals; D002934:Cinnamates / Q000494:pharmacology / Q000627:therapeutic use; D015852:Eukaryotic Initiation Factor-2 / Q000378:metabolism*; D006143:Guanabenz / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D010766:Phosphorylation / Q000187:drug effects; D013890:Thiourea / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014122:Toxoplasma / Q000187:drug effects* / Q000378:metabolism*; D014123:Toxoplasmosis / Q000188:drug therapy / Q000378:metabolism
chemical_list: D002934:Cinnamates; D015852:Eukaryotic Initiation Factor-2; C496827:salubrinal; D006143:Guanabenz; D013890:Thiourea
references: Biochem J. 2004 Jun 1;380(Pt 2):523-31
references: 14989696
references: FEMS Microbiol Rev. 2012 May;36(3):717-33
references: 22091606
references: Clin Infect Dis. 1996 Feb;22(2):268-75
references: 8838183
references: Infect Immun. 1994 May;62(5):1761-7
references: 8168938
references: J Exp Med. 2010 Jul 5;207(7):1465-74
references: 20584882
references: Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3956-61
references: 22355110
references: Expert Rev Anti Infect Ther. 2011 Jan;9(1):1-3
references: 21171869
references: Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17200-5
references: 20855600
references: Mol Cell. 2001 Jun;7(6):1165-76
references: 11430820
references: J Biol Chem. 2008 Jun 13;283(24):16591-601
references: 18420584
references: Lancet. 2004 Jun 12;363(9425):1965-76
references: 15194258
references: PLoS Pathog. 2006 Oct;2(10):e105
references: 17069459
references: Cell Microbiol. 2011 Jul;13(7):1059-77
references: 21624030
references: Nat Chem Biol. 2009 Oct;5(10):765-71
references: 19734910
references: Science. 2011 Apr 1;332(6025):91-4
references: 21385720
references: Science. 2005 Feb 11;307(5711):935-9
references: 15705855
references: Eukaryot Cell. 2011 Nov;10(11):1403-12
references: 21908594
references: Eukaryot Cell. 2013 Feb;12(2):161-7
references: 23243065
references: Biochem Soc Trans. 2006 Feb;34(Pt 1):7-11
references: 16246168
references: Drugs. 1983 Sep;26(3):212-29
references: 6352237
references: Parasitol Res. 2010 Jul;107(2):253-60
references: 20514494
references: PLoS One. 2011;6(11):e27904
references: 22114724
references: Int J Biol Sci. 2011;7(7):960-7
references: 21850205
references: Exp Parasitol. 1994 Jun;78(4):361-70
references: 8206135
references: Curr Clin Pharmacol. 2011 Nov;6(4):280-7
references: 21827389
references: J Clin Microbiol. 2000 Aug;38(8):2929-32
references: 10921953